AP-001 (ArrePath)

N/A

Report date: 2024/10/11 10:43:36
NME

Base Information

Drug NameAP-001 (ArrePath)
Drug Alias NameAP-001 (ArrePath)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsUrinary Tract InfectionsIntraabdominal InfectionsHealthcare-Associated Pneumonia +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesArrePath Inc
China Registration ClassN/A

Develop Information

Active CompaniesArrePath Inc
Inactive CompaniesN/A
Active IndicationsUrinary Tract InfectionsIntraabdominal InfectionsHealthcare-Associated Pneumonia +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A